DCF — MARSHFIELD MEDICAL CENTER NEILLSVILL
Enterprise Value: $-69.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-69.2M
Enterprise Value
$-21.7M
PV of Cash Flows
$-47.5M
PV of Terminal Value
$-76.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $38.9M | $-4.4M | -11.0% | $-6.0M | $-5.5M |
| Year 2 | $40.1M | $-4.1M | -10.0% | $-5.8M | $-4.8M |
| Year 3 | $41.3M | $-3.8M | -9.0% | $-5.6M | $-4.2M |
| Year 4 | $42.5M | $-3.7M | -9.0% | $-5.5M | $-3.8M |
| Year 5 | $43.8M | $-3.7M | -9.0% | $-5.6M | $-3.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-69.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$37.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11792441101321237
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5